Patents Assigned to CV6 THERAPEUTICS (NI) LIMITED
  • Hydantoin containing deoxyuridine triphosphatase inhibitors
    Patent number: 11584723
    Abstract: Provided herein are dUTPase inhibitors, compositions comprising such compounds and methods of using such compounds and compositions.
    Type: Grant
    Filed: May 14, 2021
    Date of Patent: February 21, 2023
    Assignee: CV6 Therapeutics (NI) Limited
    Inventors: Mark Spyvee, Pravin S. Shirude
  • Nitrogen ring linked deoxyuridine triphosphatase inhibitors
    Patent number: 11518746
    Abstract: Provided herein are dUTPase inhibitors, compositions comprising such compounds and methods of using such compounds and compositions.
    Type: Grant
    Filed: November 6, 2020
    Date of Patent: December 6, 2022
    Assignee: CV6 Therapeutics (NI) Limited
    Inventors: Mark Spyvee, Robert D. Ladner
  • Deoxyuridine triphosphatase inhibitors
    Patent number: 11479531
    Abstract: Provided herein are dUTPase inhibitors, compositions comprising such compounds and methods of using such compounds and compositions.
    Type: Grant
    Filed: March 2, 2020
    Date of Patent: October 25, 2022
    Assignees: University of Southern California, CV6 Therapeutics (NI) Limited
    Inventors: Robert D. Ladner, Mark Spyvee, Pravin S. Shirude
  • Uracil containing compounds
    Patent number: 11247984
    Abstract: Provided herein are dUTPase inhibitors, compositions comprising such compounds and methods of using such compounds and compositions.
    Type: Grant
    Filed: November 21, 2017
    Date of Patent: February 15, 2022
    Assignee: CV6 Therapeutics (NI) Limited
    Inventor: Robert D. Ladner
  • Deoxyuridine triphosphatase inhibitors containing amino sulfonyl linkage
    Patent number: 11198677
    Abstract: Provided herein are dUTPase inhibitors, compositions comprising such compounds and methods of using such compounds and compositions.
    Type: Grant
    Filed: February 24, 2020
    Date of Patent: December 14, 2021
    Assignees: University of Southern California, CV6 Therapeutics (NI) Limited
    Inventors: Robert D. Ladner, Mark Spyvee, Pravin S. Shirude
  • 6-membered uracil isosteres
    Patent number: 11174271
    Abstract: Provided herein are dUTPase inhibitors, compositions comprising such compounds and methods of using such compounds and compositions.
    Type: Grant
    Filed: November 21, 2017
    Date of Patent: November 16, 2021
    Assignee: CV6 Therapeutics (NI) Limited
    Inventors: Mark Spyvee, Michael Lewis
  • Amino sulfonyl compounds
    Patent number: 11168059
    Abstract: Provided herein are dUTPase inhibitors, compositions comprising such compounds and methods of using such compounds and compositions.
    Type: Grant
    Filed: November 21, 2017
    Date of Patent: November 9, 2021
    Assignee: CV6 Therapeutics (NI) Limited
    Inventor: Mark Spyvee
  • Deoxyuridine triphosphatase inhibitors containing cyclopropano linkage
    Patent number: 11124485
    Abstract: Provided herein are dUTPase inhibitors of Formula (I), compositions comprising such compounds and methods of using such compounds and compositions
    Type: Grant
    Filed: January 27, 2020
    Date of Patent: September 21, 2021
    Assignee: CV6 Therapeutics (NI) Limited
    Inventors: Mark Spyvee, Pravin S. Shirude
  • Hydantoin containing deoxyuridine triphosphatase inhibitors
    Patent number: 11104649
    Abstract: Provided herein are dUTPase inhibitors, compositions comprising such compounds and methods of using such compounds and compositions.
    Type: Grant
    Filed: May 4, 2020
    Date of Patent: August 31, 2021
    Assignee: CV6 Therapeutics (NI) Limited
    Inventors: Mark Spyvee, Pravin S. Shirude
  • Hydantoin containing deoxyuridine triphosphatase inhibitors
    Patent number: 11014924
    Abstract: Provided herein are dUTPase inhibitors, compositions comprising such compounds and methods of using such compounds and compositions.
    Type: Grant
    Filed: November 21, 2017
    Date of Patent: May 25, 2021
    Assignee: CV6 Therapeutics (NI) Limited
    Inventors: Mark Spyvee, Robert D. Ladner
  • Hydantoin containing deoxyuridine triphosphatase inhibitors
    Patent number: 10858344
    Abstract: Provided herein are dUTPase inhibitors, compositions comprising such compounds and methods of using such compounds and compositions.
    Type: Grant
    Filed: November 21, 2017
    Date of Patent: December 8, 2020
    Assignee: CV6 Therapeutics (NI) Limited
    Inventor: Mark Spyvee
  • Nitrogen ring linked deoxyuridine triphosphatase inhibitors
    Patent number: 10829457
    Abstract: Provided herein are dUTPase inhibitors, compositions comprising such compounds and methods of using such compounds and compositions.
    Type: Grant
    Filed: November 21, 2017
    Date of Patent: November 10, 2020
    Assignee: CV6 THERAPEUTICS (NI) LIMITED
    Inventors: Mark Spyvee, Robert D. Ladner
  • Deoxyuridine triphosphatase inhibitors
    Patent number: 10577321
    Abstract: Provided herein are dUTPase inhibitors, compositions comprising such compounds and methods of using such compounds and compositions.
    Type: Grant
    Filed: July 7, 2016
    Date of Patent: March 3, 2020
    Assignees: University of Southern California, CV6 Therapeutics (NI) Limited
    Inventors: Robert D. Ladner, Mark Spyvee, Pravin S. Shirude
  • Hydantoin containing deoxyuridine triphosphatase inhibitors
    Patent number: 10570098
    Abstract: Provided herein are dUTPase inhibitors, compositions comprising such compounds and methods of using such compounds and compositions.
    Type: Grant
    Filed: July 7, 2016
    Date of Patent: February 25, 2020
    Assignee: CV6 Therapeutics (NI) Limited
    Inventors: Mark Spyvee, Pravin S. Shirude
  • Deoxyuridine triphosphatase inhibitors containing amino sulfonyl linkage
    Patent number: 10570100
    Abstract: Provided herein are dUTPase inhibitors, compositions comprising such compounds and methods of using such compounds and compositions.
    Type: Grant
    Filed: July 7, 2016
    Date of Patent: February 25, 2020
    Assignees: University of Southern California, CV6 Therapeutics (NI) Limited
    Inventors: Robert D. Ladner, Mark Spyvee, Pravin S. Shirude
  • Hydantoin containing deoxyuridine triphosphatase inhibitors
    Patent number: 10562860
    Abstract: Provided herein are dUTPase inhibitors, compositions comprising such compounds and methods of using such compounds and compositions.
    Type: Grant
    Filed: March 7, 2018
    Date of Patent: February 18, 2020
    Assignee: CV6 Therapeutics (NI) Limited
    Inventors: Mark Spyvee, Pravin S. Shirude
  • Deoxyuridine triphosphatase inhibitors containing cyclopropano linkage
    Patent number: 10544105
    Abstract: Provided herein are dUTPase inhibitors of Formula (I), compositions comprising such compounds and methods of using such compounds and compositions
    Type: Grant
    Filed: July 7, 2016
    Date of Patent: January 28, 2020
    Assignee: CV6 THERAPEUTICS (NI) LIMITED
    Inventors: Mark Spyvee, Pravin S. Shirude